Hepatic ischemia-reperfusion injury (IRI) is a multifactorial phenomenon which has been
associated with adverse clinical outcomes. IRI related tissue damage is characterized by …

Donor organ shortage still remains a serious obstacle for the access of wait-list patients to
kidney transplantation, the best treatment for End-Stage Kidney Disease (ESKD). To expand …

Purpose of review: The emerging field of molecular predictive medicine is aiming to change
the traditional medical approach in renal transplantation. Many studies have explored …

Ischemia-reperfusion injury (IRI) after renal transplantation is a complex biochemical
process. The first component is an ischemic phase during kidney storage. The second is …

Solid organ transplantation is a life-saving intervention for patients suffering from end-stage
organ failure. Although improvements in surgical techniques, standards of care, and …

Transplant centers are currently facing a lack of tools to ensure adequate evaluation of the
quality of the available organs, as well as a significant shortage of kidney donors. Therefore …

Ischemia-reperfusion injury (IRI) occurring after renal transplantation is a complex
biochemical process that can be monitored by specific biomarkers. The roles of those are …

Background Ex vivo lung perfusion (EVLP) is a useful technique for evaluating and repairing
donor lungs for transplantation. However, studies examining the effects of perfusate …

Background. Ischemia-free liver transplantation (IFLT) has been innovated to avoid graft
ischemia during organ procurement, preservation, and implantation. However, the …

Background. Ischemia-related injury during the preimplantation period impacts kidney graft
outcome. Evaluating these lesions by a noninvasive approach before transplantation could …